4Filing Date: Mar 2, 2026

Hims & Hers Health 4: Boughton Soleil sold 4,651 shares of Class A Common Stock a… (Mar 2, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001773751-26-000029
Total Value$70.7K
Trades1
Insiders1

Transaction Details

Boughton Soleil
Chief Legal Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-4.65K
Price$15.21
Total Value$70.7K
Shares Owned After440.97K
Transaction DateFeb 27, 2026
10b5-1
Footnotes ▸

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.

Post-Transaction Holdings

Boughton Soleil · Chief Legal Officer
SecuritySharesChange
Class A Common Stock440.97K-4.65K (-1.04%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-27 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Boughton Soleil CIK: 0001837817 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-02-27 | Code: S (Open market sale) Shares: -4,651 | Price: $15.21 Total Value: $70,741.71 Shares Owned After: 440,972 | Ownership: D (Direct) Footnotes: [F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person. --- Footnotes (Complete Index) --- F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton (2026-03-02)

keid analysis is for reference only and does not constitute investment advice.